Resveratrol Cải Thiện Tổn Thương Thiếu Máu - Tưới Máu Lại Ở Võng Mạc Bằng Cách Điều Chỉnh Đường Dẫn NLRP3 Inflammasome Và Keap1/Nrf2/HO-1

Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N (2020) The diagnosis and treatment of glaucoma. Dtsch Arztebl Int 117(13):225–234. https://doi.org/10.3238/arztebl.2020.0225 Kang JM, Tanna AP (2021) Glaucoma. Med Clin North Am 105(3):493–510. https://doi.org/10.1016/j.mcna.2021.01.004 Stein JD, Khawaja AP, Weizer JS (2021) Glaucoma in adults-screening, diagnosis, and management: a review. JAMA 325(2):164–174. https://doi.org/10.1001/jama.2020.21899 Huang Y, Xu W, Zhou R (2021) NLRP3 inflammasome activation and cell death. Cell Mol Immunol 18(9):2114–2127. https://doi.org/10.1038/s41423-021-00740-6 Wang L, Hauenstein AV (2020) The NLRP3 inflammasome: mechanism of action, role in disease and therapies. Mol Aspects Med 76:100889. https://doi.org/10.1016/j.mam.2020.100889 Wang M, Pan W, Xu Y, Zhang J, Wan J, Jiang H (2022) Microglia-mediated neuroinflammation: a potential target for the treatment of cardiovascular diseases. J Inflamm Res 15:3083–3094. https://doi.org/10.2147/JIR.S350109 Shen S, Wang Z, Sun H, Ma L (2022) Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling. Med Sci Monit 28:e934255. https://doi.org/10.12659/MSM.934255 8, Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, Bitto A, Crea G et al (2016) ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev 2016:2183026. https://doi.org/10.1155/2016/2183026 Toldo S, Abbate A (2018) The NLRP3 inflammasome in acute myocardial infarction. Nat Rev Cardiol 15(4):203–214. https://doi.org/10.1038/nrcardio.2017.161 Ulasov AV, Rosenkranz AA, Georgiev GP, Sobolev AS (2022) Nrf2/Keap1/ARE signaling: towards specific regulation. Life Sci 291:120111. https://doi.org/10.1016/j.lfs.2021.120111 Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22). https://doi.org/10.3390/molecules25225474 Panisello-Roselló GBR, Sanchez-Nuno A, Alva S, Roselló-Catafau N, Carbonell J T (2022) Nrf2 and oxidative stress in liver ischemia/reperfusion injury. Febs J 289(18):5463–5479. https://doi.org/10.1111/febs.16336 Yu C, Xiao JH (2021) The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev 2021:6635460. https://doi.org/10.1155/2021/6635460 Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J (2016) Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci 73(17):3221–3247. https://doi.org/10.1007/s00018-016-2223-0 Zhang Q, Liu J, Duan H, Li R, Peng W, Wu C (2021) Activation of Nrf2/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress. J Adv Res 34:43–63. https://doi.org/10.1016/j.jare.2021.06.023 Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R (2021) The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of celastrol in Parkinson’s disease. Redox Biol 47:102134. https://doi.org/10.1016/j.redox.2021.102134 Bian H, Wang G, Huang J, Liang L, Zheng Y, Wei Y, Wang H, Xiao L et al (2020) Dihydrolipoic acid protects against lipopolysaccharide-induced behavioral deficits and neuroinflammation via regulation of Nrf2/HO-1/NLRP3 signaling in rat. J Neuroinflammation 17(1):166. https://doi.org/10.1186/s12974-020-01836-y Wu Y, Qiu G, Zhang H, Zhu L, Cheng G, Wang Y, Li Y, Wu W (2021) Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway. J Cell Mol Med 25(21):9983–9994. https://doi.org/10.1111/jcmm.16871 Xiao L, Dai Z, Tang W, Liu C, Tang B (2021) Astragaloside IV alleviates cerebral ischemia-reperfusion injury through NLRP3 inflammasome-mediated pyroptosis inhibition via activating Nrf2. Oxid Med Cell Longev 2021:9925561. https://doi.org/10.1155/2021/9925561 Cheng Y, Cheng L, Gao X, Chen S, Wu P, Wang C, Liu Z (2021) Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. Theranostics 11(2):861–877. https://doi.org/10.7150/thno.48436 Qi Y, Zhao M, Bai Y, Huang L, Yu W, Bian Z, Zhao M, Li X (2014) Retinal ischemia/reperfusion injury is mediated by toll-like receptor 4 activation of NLRP3 inflammasomes. Invest Ophthalmol Vis Sci 55(9):5466–5475. https://doi.org/10.1167/iovs.14-14380 Su CF, Jiang L, Zhang XW, Iyaswamy A, Li M (2021) Resveratrol in rodent models of Parkinson’s disease: a systematic review of experimental studies. Front Pharmacol 12:644219. https://doi.org/10.3389/fphar.2021.644219 Hecker A, Schellnegger M, Hofmann E, Luze H, Nischwitz SP, Kamolz LP, Kotzbeck P (2022) The impact of resveratrol on skin wound healing, scarring, and aging. Int Wound J 19(1):9–28. https://doi.org/10.1111/iwj.13601 Khorshidi F, Poljak A, Liu Y, Lo JW, Crawford JD, Sachdev PS (2021) Resveratrol: a miracle drug in neuropsychiatry or a cognitive enhancer for mice only? A systematic review and meta-analysis. Ageing Res Rev 65:101199. https://doi.org/10.1016/j.arr.2020.101199 Mahdavi A, Bagherniya M, Mirenayat MS, Atkin SL, Sahebkar A (2021) Medicinal plants and phytochemicals regulating insulin resistance and glucose homeostasis in type 2 diabetic patients: a clinical review. Adv Exp Med Biol 1308:161–183. https://doi.org/10.1007/978-3-030-64872-5_13 Sun ZM, Guan P, Luo LF, Qin LY, Wang N, Zhao YS, Ji ES (2020) Resveratrol protects against CIH-induced myocardial injury by targeting Nrf2 and blocking NLRP3 inflammasome activation. Life Sci 245:117362. https://doi.org/10.1016/j.lfs.2020.117362 Ji K, Li Z, Lei Y, Xu W, Ouyang L, He T, Xing Y (2021) Resveratrol attenuates retinal ganglion cell loss in a mouse model of retinal ischemia reperfusion injury via multiple pathways. Exp Eye Res 209:108683. https://doi.org/10.1016/j.exer.2021.108683 Sun YY, Zhu HJ, Zhao RY, Zhou SY, Wang MQ, Yang Y, Guo ZN (2023) Remote ischemic conditioning attenuates oxidative stress and inflammation via the Nrf2/HO-1 pathway in MCAO mice. Redox Biol 66:102852. https://doi.org/10.1016/j.redox.2023.102852 Li J, Xu P, Hong Y, Xie Y, Peng M, Sun R, Guo H, Zhang X et al (2023) Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury. J Neuroinflammation 20(1):148. https://doi.org/10.1186/s12974-023-02819-5 Hu R, Luo H, Ji Y, Wang Z, Zheng P, Ouyang H, Wang X, Wang Y et al (2023) Activation of NLRP3 signaling contributes to cadmium-induced bone defects, associated with autophagic flux obstruction. Sci Total Environ 893:164787. https://doi.org/10.1016/j.scitotenv.2023.164787 Yang J, Yang N, Luo J, Cheng G, Zhang X, He T, Xing Y (2020) Overexpression of S100A4 protects retinal ganglion cells against retinal ischemia-reperfusion injury in mice. Exp Eye Res 201:108281. https://doi.org/10.1016/j.exer.2020.108281 Franke M, Bieber M, Kraft P, Weber A, Stoll G, Schuhmann MK (2021) The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice. Brain Behav Immun 92:223–233. https://doi.org/10.1016/j.bbi.2020.12.009 Tang TT, Lv LL, Pan MM, Wen Y, Wang B, Li ZL, Wu M, Wang FM et al (2018) Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis 9(3):351. https://doi.org/10.1038/s41419-018-0378-3 Qin Q, Yu N, Gu Y, Ke W, Zhang Q, Liu X, Wang K, Chen M (2022) Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury. Cell Death Dis 13(5):507. https://doi.org/10.1038/s41419-022-04911-9 Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M (2022) Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther 7(1):131. https://doi.org/10.1038/s41392-022-00955-7 Madhu LN, Kodali M, Attaluri S, Shuai B, Melissari L, Rao X, Shetty AK (2021) Melatonin improves brain function in a model of chronic Gulf War illness with modulation of oxidative stress, NLRP3 inflammasomes, and BDNF-ERK-CREB pathway in the hippocampus. Redox Biol 43:101973. https://doi.org/10.1016/j.redox.2021.101973 Sharma BR, Kanneganti TD (2021) NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 22(5):550–559. https://doi.org/10.1038/s41590-021-00886-5 Chen H, Deng Y, Gan X, Li Y, Huang W, Lu L, Wei L, Su L et al (2020) NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener 15(1):26. https://doi.org/10.1186/s13024-020-00372-w Liu M, Li H, Yang R, Ji D, Xia X (2022) GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma. J Neuroinflammation 19(1):262. https://doi.org/10.1186/s12974-022-02626-4 Liu J, Zhang N, Zhang M, Yin H, Zhang X, Wang X, Wang X, Zhao Y (2021) N-acetylserotonin alleviated the expression of interleukin-1β in retinal ischemia-reperfusion rats via the TLR4/NF-κB/NLRP3 pathway. Exp Eye Res 208:108595. https://doi.org/10.1016/j.exer.2021.108595 Zhao W, Huang X, Han X, Hu D, Hu X, Li Y, Huang P, Yao W (2018) Resveratrol suppresses gut-derived NLRP3 inflammasome partly through stabilizing mast cells in a rat model. Mediators Inflamm 2018:6158671. https://doi.org/10.1155/2018/6158671 He Q, Li Z, Wang Y, Hou Y, Li L, Zhao J (2017) Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction. Int Immunopharmacol 50:208–215. https://doi.org/10.1016/j.intimp.2017.06.029 Li H, Zheng F, Zhang Y, Sun J, Gao F, Shi G (2022) Resveratrol, novel application by preconditioning to attenuate myocardial ischemia/reperfusion injury in mice through regulate AMPK pathway and autophagy level. J Cell Mol Med 26(15):4216–4229. https://doi.org/10.1111/jcmm.17431 Rojo DLVM, Chapman E, Zhang DD (2018) NRF2 and the hallmarks of cancer. Cancer Cell 34(1):21–43. https://doi.org/10.1016/j.ccell.2018.03.022 Qin X, Li N, Zhang M, Lin S, Zhu J, Xiao D, Cui W, Zhang T et al (2019) Tetrahedral framework nucleic acids prevent retina ischemia-reperfusion injury from oxidative stress via activating the Akt/Nrf2 pathway. Nanoscale 11(43):20667–20675. https://doi.org/10.1039/c9nr07171g Arioz BI, Tastan B, Tarakcioglu E, Tufekci KU, Olcum M, Ersoy N, Bagriyanik A, Genc K et al (2019) Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1/Nrf2 pathway. Front Immunol 10:1511. https://doi.org/10.3389/fimmu.2019.01511 Yang H, Lv H, Li H, Ci X, Peng L (2019) Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways. Cell Commun Signal 17(1):62. https://doi.org/10.1186/s12964-019-0366-y Lin Y, Luo T, Weng A, Huang X, Yao Y, Fu Z, Li Y, Liu A et al (2020) Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol 11:580593. https://doi.org/10.3389/fimmu.2020.580593 Satoh T, Trudler D, Oh CK, Lipton SA (2022) Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer’s disease, Parkinson’s disease, and Long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxid (Basel) 11(1). https://doi.org/10.3390/antiox11010124 Dai Y, Zhang J, Xiang J, Li Y, Wu D, Xu J (2019) Calcitriol inhibits ROS-NLRP3-IL-1β signaling axis via activation of Nrf2-antioxidant signaling in hyperosmotic stress stimulated human corneal epithelial cells. Redox Biol 21:101093. https://doi.org/10.1016/j.redox.2018.101093 Liu Q, Zhang F, Zhang X, Cheng R, Ma JX, Yi J, Li J (2018) Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Mol Cell Biochem 445(1–2):105–115. https://doi.org/10.1007/s11010-017-3256-x